ARCHIVES

Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Amgen’s Kepivance Approved For Severe Oral Mucositis

January 28, 2005

Food & Water Inc. Launches ‘Cancer Prevention Campaign’

May 1, 1992

BRAF Mutation Testing Classifies Indeterminate FNA Samples

March 29, 2013

Bennett Of NYU Heads NCI Director Search Committee

March 11, 1977

Options For Changes, Some Drastic, In Cooperative Groups Suggested By CTEP

April 11, 1986

NCI RFAs Available

May 5, 2000